The assessment of sphincter saving resection (SSR) for the treatment of low rectal carcinoma

郁宝铭,李东华,沈耀祥,郑民华,王灏
DOI: https://doi.org/10.3760/cma.j.issn.1007-631X.1998.06.112
1998-01-01
Abstract:Objective:This paper is to elucidate the role of SSR in low rectal carcinoma.Methods:2074 cases of rectal carcinoma were treated surgically between January 1954 through December 1996, among which 1594 lesions situated below the peritoneal reflection accounting for 76.86% of the total cases. Tumors in 1 304 out of 1 594 cases were resectable, with a resectability rate of 81.81% in low rectal carcinoma and SSR was carried out in 441 cases (33.82%).Results:The SSR ratio was 16.05% in Group Ⅰ (before the year of 80s'), 40.76% in Group Ⅱ (during the period of 80s') and 49.75% in Group Ⅲ (in 90s'). Dixon's operation was the preferable procedure in SSR and accounted for 39.02% in Group Ⅰ, 62.73% in Group Ⅱ and 70.71% in Group Ⅲ. The overall operative mortality rate in SSR was 0.45%. The incidence of anastomotic leakage following Dixon's operation was 8.06% and 61 cases in Group Ⅲ underwent ultra-low anastomosis with an anastomotic leakage rate of 6.58% (4/61). The local recurrence rate following Mile's procedure was 12.46%, and 13.15% in all cases following SSR, with the rate of 12.20% in Group Ⅰ, 13.66% in Group Ⅱ and 12.63% in Group Ⅲ, respectively (P>0.05). The 5 year survival rate in Group Ⅰ was (63±5)%, (70±4)% in Group Ⅱ and (82±4)% in Group Ⅲ(P<0.05).Conclusions:Selective SSR in low rectal carcinoma has a comparable good long term results as Mile's procedure. Perioperative intensive and comprehensive therapy underlay the improvement of long-term results in recent years.
What problem does this paper attempt to address?